What is the best upfront chemotherapy option for patients with colorectal cancer (CRC) and unresectable liver metastases? A new report demonstrated why patients benefit most from starting on a ...
Medical experts review therapy options for metastatic colorectal cancer after FOLFOX/FOLFIRI, emphasizing regorafenib, FTD/TPI plus or minus bevacizumab, and fruquintinib due to the rarity of ...
Contextual Framework for Understanding Treatment De-Escalation in Patients With Breast Cancer Fig 1. Summary of key management of locally advanced rectal cancer guideline recommendations. The ...
A phase 2 study of BOLD-100 in combination with FOLFOX chemotherapy in patients with advanced gastric cancer: Efficacy and safety analysis (BOLD-100-001). This is an ASCO Meeting Abstract from the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback